Skip to main content

Table 3 Characteristics of patient clusters

From: Cluster analysis of sputum cytokine-high profiles reveals diversity in T(h)2-high asthma patients

CLUSTER

1

2

3

4

5

P value

Subjects (n=)

24

16

8

25

132

 

Age (years)

44.0 ± 13.4

47.3 ± 14.1

39.0 ± 15.4

38.0 ± 12.7

40.2 ± 12.7

0.14

Gender (M/F)

12/12

6/10

4/4

11/14

62/70

0.95

Body Mass Index

22.5–26.8–28.8

21.2–25.4–29.9

20.7–23.5–30.9

21.9–23.6–26.0

21.8–24.3–28.7

0.55

Active smoking (%)

9

0

0

19

19

0.27

Atopy (%)

73

62

88

73

80

0.54

Steroid-naive (%)

8

18

12

20

23

0.82

Inhaled steroids only (%)

79

75

50

68

68

0.58

Inhaled and oral steroids (%)

13

7

38

12

9

0.15

FEV1, % predicted

86.0 ± 17.7

93.9 ± 17.5

95.6 ± 18.8

95.2 ± 21.4

96.1 ± 18.7

0.21

FEV1/FVC

69.0 ± 12.0

72.5 ± 8.1

71.3 ± 13.1

71.3 ± 13.4

73.1 ± 11.3

0.57

PEF, % predicted

90.0 ± 19.7

91.8 ± 18.5

96.9 ± 26.6

88.8 ± 26.7

97.5 ± 19.5

0.30

FEF25–75, % predicted

53.5 ± 25.6

55.5 ± 23.0

67.2 ± 41.4

67.8 ± 35.4

67.2 ± 30.6

0.29

FENO (ppb)

16.8–27.2–48.1

12.1–6.7–29.5

16.1–27.9–43.3

13.9–24.3–55.1

13.3–21.2–37.2

0.46

Sputum eosinophils (%)

0.6–2.0–31.1

0.2–1.0–8.0

0.0–1.0–4.0

0.0–0.8–2.0

0.0–1.0–4.0†††

0.36

Sputum neutrophils (%)

23.5–51.9–81.6*,†

29.5–64.0–73.8

22.0–32.0–62.4

37.0–55.0–77.9**,††

11.8–24.8–49.5

<0.0001

  1. Clinical, lung function and inflammatory parameters in different asthma patients clusters defined by their sputum cytokine profile. Cluster 1: n = 24; IL-5-high and IL-17A-high, cluster 2: n = 16; IL-5-high and IL-10-high and IL-17 F-low, cluster 8: n = 15; IL-6-high, cluster 4: n = 25; IL-22-high, cluster 5: n = 132; normal levels of the previous cytokines with or without an IL-1β or TNF low profile. Normally distributed data were represented as mean ± standard deviation and analyzed by ANOVA. Data that were not normally distributed were represented as median and 25–75% (interquartile range) percentile and analyzed by Kruskal-Wallis test. Dunn’s Multiple Comparison test was used as a post hoc test. *,** p < 0.05, p < 0.01 respectively compared to cluster 5, †,††,††† p < 0.05, p < 0.01 and p < 0.001 respectively compared to mean/median level in asthmatics. FEV 1 Forced Expiratory Volume in 1 second, FVC Forced Vital Capacity, PEF Peak Expiratory Flow, FEF 25–75% Forced expiratory Flow at 25–75% interval, F E NO Fraction of exhaled Nitric Oxide